Stock Analysis on Net
Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Regeneron Pharmaceuticals Inc. for $13.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Analysis of Debt

Advanced level

Total Debt (Carrying Amount)

Regeneron Pharmaceuticals Inc., balance sheet: debt

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Finance lease liabilities, current portion
Long-term debt
Finance lease liabilities, excluding current portion
Total debt (carrying amount)

Based on: 10-K (filing date: 2021-02-08), 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09).

Debt item Description The company
Total debt (carrying amount) Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. Regeneron Pharmaceuticals Inc.’s total debt increased from 2018 to 2019 and from 2019 to 2020.

Total Debt (Fair Value)

Microsoft Excel LibreOffice Calc
Dec 31, 2020
Selected Financial Data (US$ in thousands)
Long-term debt
Finance lease liabilities
Total debt (fair value)
Financial Ratio
Debt, fair value to carrying amount ratio

Based on: 10-K (filing date: 2021-02-08).


Weighted-average Interest Rate on Debt

Weighted-average interest rate on debt:

Interest rate Debt amount1 Interest rate × Debt amount Weighted-average interest rate2
Total

Based on: 10-K (filing date: 2021-02-08).

1 US$ in thousands

2 Weighted-average interest rate = 100 × ÷ =